ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Hawk70
|
385 |
184K |
5 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
385
|
184K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Hawk70
|
385 |
184K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
385
|
184K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Hawk70
|
385 |
184K |
6 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
385
|
184K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Hawk70
|
12K |
4.0M |
5 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
12K
|
4.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Hawk70
|
12K |
4.0M |
23 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
12K
|
4.0M
|
23
|
|
ASX - By Stock
|
LDX |
Re:
The re-rate journey
|
|
Hawk70
|
496 |
126K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
496
|
126K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
The re-rate journey
|
|
Hawk70
|
496 |
126K |
2 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
496
|
126K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Confirmatory Phase 3 Back Pain Trial Actively Enrols
|
|
Hawk70
|
47 |
22K |
4 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
47
|
22K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Hawk70
|
1.3K |
434K |
10 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
1.3K
|
434K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Hawk70
|
1.3K |
434K |
26 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
1.3K
|
434K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Hawk70
|
1.3K |
434K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
1.3K
|
434K
|
2
|
|
ASX - Day Trading
|
|
Re:
Morning Trading July 16
|
|
Hawk70
|
248 |
41K |
0 |
16/07/24 |
16/07/24 |
ASX - Day Trading
|
248
|
41K
|
0
|
|
ASX - By Stock
|
TVN |
Re:
Ann: TVN Update on Acquisition of the Speewah Project
|
|
Hawk70
|
23 |
10K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
23
|
10K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Expands Henry Schein FebriDx Distribution Partnership
|
|
Hawk70
|
63 |
11K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
63
|
11K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
Hawk70
|
131 |
60K |
12 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
131
|
60K
|
12
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Expands Henry Schein FebriDx Distribution Partnership
|
|
Hawk70
|
63 |
11K |
2 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
63
|
11K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
2 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
67
|
15K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Hawk70
|
2.0K |
441K |
0 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
2.0K
|
441K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
67
|
15K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Change in substantial holding
|
|
Hawk70
|
16 |
5.2K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
16
|
5.2K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
The re-rate journey
|
|
Hawk70
|
496 |
126K |
9 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
496
|
126K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
Hawk70
|
1.3K |
434K |
10 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
1.3K
|
434K
|
10
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
1 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
0 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
1 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
0 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
Hawk70
|
131 |
60K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
131
|
60K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
1 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
67
|
15K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
15K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Hawk70
|
67 |
15K |
2 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
15K
|
2
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Quarterly Activities Report & Appendix 4C
|
|
Hawk70
|
33 |
11K |
5 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
33
|
11K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Hawk70
|
67 |
25K |
11 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
25K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
once approved
|
|
Hawk70
|
131 |
60K |
34 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
131
|
60K
|
34
|
|
ASX - By Stock
|
LDX |
Re:
LDX Chart
|
|
Hawk70
|
2.0K |
441K |
4 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
2.0K
|
441K
|
4
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Nyrada Quarterly Activities Report & Appendix 4C
|
|
Hawk70
|
33 |
11K |
1 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
2 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
109K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
5 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
109K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
109K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
36 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
265
|
109K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
6 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
109K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Resubmits BLA with FDA for Ryoncil Approval
|
|
Hawk70
|
265 |
109K |
0 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
265
|
109K
|
0
|
|
ASX - By Stock
|
I88 |
Re:
Ann: Soil Grades up to 74,997 ppm U3O8 (7.5%) at Portland Creek
|
|
Hawk70
|
555 |
169K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
555
|
169K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Expands Henry Schein FebriDx Distribution Partnership
|
|
Hawk70
|
63 |
11K |
2 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
63
|
11K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Expands Henry Schein FebriDx Distribution Partnership
|
|
Hawk70
|
63 |
11K |
1 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
63
|
11K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
Hawk70
|
617 |
305K |
0 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
617
|
305K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of RP11 Multiple Dose Trial
|
|
Hawk70
|
55 |
22K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
55
|
22K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Hawk70
|
995 |
456K |
9 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
995
|
456K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
Hawk70
|
995 |
456K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
995
|
456K
|
4
|
|